This article highlights the key trends shaping the pharmaceutical industry in 2025, including the growing role of artificial intelligence, gene editing technologies, biosimilars, and real-world data.
It explains how these innovations are transforming drug discovery, development, and commercialization, helping pharma and biotech companies improve efficiency, reduce costs, and accelerate time to market.
- AI is accelerating drug discovery and development
- Gene editing is enabling more precise therapies
- Biosimilars are improving patient access and affordability
- Real-world data is supporting better regulatory and clinical decisions
